结直肠癌肝转移组织病理学生长方式研究进展

国际肿瘤学杂志››2024,Vol. 51››Issue (2): 114-118.doi:10.3760/cma.j.cn371439-20231016-00017

结直肠癌肝转移组织病理学生长方式研究进展

孙国宝, 杨倩, 庄庆春, 高斌斌, 孙晓刚, 宋伟, 沙丹()

betway必威登陆网址附属省立医院肿瘤微创科，济南 250021

收稿日期:2023-10-16修回日期:2024-01-20出版日期:2024-02-08发布日期:2024-04-03
通讯作者:沙丹，Email： shadan@sdfmu.edu.cn
基金资助:
山东省自然科学基金(ZR2021MH140);济南市临床医学科技创新计划(202019085)

Research progress on the histopathological growth patterns of colorectal liver metastasis

Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan()

Department of Minimally Invasive Treatment of Cancer，Shandong Provincial Hospital Affiliated to Shandong First Medical University，Jinan 250021，China

Received:2023-10-16Revised:2024-01-20Online:2024-02-08Published:2024-04-03
Contact:Sha Dan，Email： shadan@sdfmu.edu.cn
Supported by:
Natural Science Foundation of Shandong Province of China(ZR2021MH140);Science and Technology Innovation Development Program of Jinan of Shandong Province(202019085)

摘要/Abstract

摘要：

结直肠癌（CRC）肝转移瘤的不同组织病理学生长方式（HGP）反映了肿瘤与宿主之间复杂而多变的相互作用。探讨HGP肿瘤血管化特点和免疫特征、HGP与抗肿瘤治疗疗效的关系以及HGP预测方法对于制定最佳治疗方案、评估患者预后和监测疾病进展具有潜在的临床应用价值。

孙国宝, 杨倩, 庄庆春, 高斌斌, 孙晓刚, 宋伟, 沙丹. 结直肠癌肝转移组织病理学生长方式研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 114-118.

Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan. Research progress on the histopathological growth patterns of colorectal liver metastasis[J]. Journal of International Oncology, 2024, 51(2): 114-118.

参考文献32

[1]	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3): 209-249. DOI:10.3322/caac.21660.
[2]	Rahbari NN, Carr PR, Jansen L, et al. Time of metastasis and outcome in colorectal cancer[J].Ann Surg,2019,269(3): 494-502. DOI:10.1097/SLA.0000000000002564. pmid:29064893
[3]	Siegel RL, Wagle NS, Cercek A, et al. Colorectal cancer statistics, 2023[J].CA Cancer J Clin,2023,73(3): 233-254. DOI:10.3322/caac.21772.
[4]	Wu Y, Mao A, Wang H, et al. Association of simultaneous vs delayed resection of liver metastasis with complications and survival among adults with colorectal cancer[J].JAMA Netw Open,2022,5(9): e2231956. DOI:10.1001/jamanetworkopen.2022.31956.
[5]	van Dam PJ, van der Stok EP, Teuwen LA, et al. International consensus guidelines for scoring the histopathological growth patterns of liver metastasis[J].Br J Cancer,2017,117(10): 1427-1441. DOI:10.1038/bjc.2017.334.
[6]	Latacz E, Höppener D, Bohlok A, et al. Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights[J].Br J Cancer,2022,127(6): 988-1013. DOI:10.1038/s41416-022-01859-7.
[7]	Vermeulen PB, Colpaert C, Salgado R, et al. Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia[J].J Pathol,2001,195(3): 336-342. DOI:10.1002/path.966. pmid:11673831
[8]	Stessels F, Van den Eynden G, Van der Auwera I, et al. Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia[J].Br J Cancer,2004,90(7): 1429-1436. DOI:10.1038/sj.bjc.6601727.
[9]	Galjart B, Nierop PMH, van der Stok EP, et al. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases[J].Angiogenesis,2019,22(2): 355-368. DOI:10.1007/s10456-019-09661-5. pmid:30637550
[10]	Haas G, Fan S, Ghadimi M, et al. Different forms of tumor vascularization and their clinical implications focusing on vessel co-option in colorectal cancer liver metastases[J].Front Cell Dev Biol,2021,9: 612774. DOI:10.3389/fcell.2021.612774.
[11]	Frentzas S, Simoneau E, Bridgeman VL, et al. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases[J].Nat Med,2016,22(11): 1294-1302. DOI:10.1038/nm.4197. pmid:27748747
[12]	Latacz E, Caspani E, Barnhill R, et al. Pathological features of vessel co-option versus sprouting angiogenesis[J].Angiogenesis,2020,23(1): 43-54. DOI:10.1007/s10456-019-09690-0. pmid:31655928
[13]	Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point[J].Nature,2017,541(7637): 321-330. DOI:10.1038/nature21349.
[14]	Stremitzer S, Vermeulen P, Graver S, et al. Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases[J].Br J Cancer,2020,122(10): 1518-1524. DOI:10.1038/s41416-020-0812-z.
[15]	Höppener DJ, Nierop PMH, Hof J, et al. Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis[J].Br J Cancer,2020,123(2): 196-206. DOI:10.1038/s41416-020-0881-z.
[16]	Liang JY, Xi SY, Shao Q, et al. Histopathological growth patterns correlate with the immunoscore in colorectal cancer liver metastasis patients after hepatectomy[J].Cancer Immunol Immunother,2020,69(12): 2623-2634. DOI:10.1007/s00262-020-02632-6.
[17]	Garcia-Vicién G, Mezheyeuski A, Micke P, et al. Spatial immunology in liver metastases from colorectal carcinoma according to the histologic growth pattern[J].Cancers (Basel),2022,14(3): 689. DOI:10.3390/cancers14030689.
[18]	Jongsma MME, Aardoom MA, Cozijnsen MA, et al. First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial[J].Gut,2022,71(1): 34-42. DOI:10.1136/gutjnl-2020-322339. pmid:33384335
[19]	Yu J, Green MD, Li S, et al. Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination[J].Nat Med,2021,27(1): 152-164. DOI:10.1038/s41591-020-1131-x. pmid:33398162
[20]	Höppener DJ, Nierop PMH, Herpel E, et al. Histopathological growth patterns of colorectal liver metastasis exhibit little heterogeneity and can be determined with a high diagnostic accuracy[J].Clin Exp Metastasis,2019,36(4): 311-319. DOI:10.1007/s10585-019-09975-0.
[21]	Buisman FE, van der Stok EP, Galjart B, et al. Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases[J].Clin Exp Metastasis,2020,37(5): 593-605. DOI:10.1007/s10585-020-10048-w.
[22]	Rigamonti A, Feuerhake F, Donadon M, et al. Histopathological and immune prognostic factors in colo-rectal liver metastases[J].Cancers (Basel),2021,13(5): 1075. DOI:10.3390/cancers13051075.
[23]	Höppener DJ, Galjart B, Nierop PMH, et al. Histopathological growth patterns and survival after resection of colorectal liver metastasis: an external validation study[J].JNCI Cancer Spectr,2021,5(3): pkab026. DOI:10.1093/jncics/pkab026.
[24]	Viganò L, Branciforte B, Laurenti V, et al. The histopathological growth pattern of colorectal liver metastases impacts local recurrence risk and the adequate width of the surgical margin[J].Ann Surg Oncol,2022,29(9): 5515-5524. DOI:10.1245/s10434-022-11717-8.
[25]	Nierop PMH, Galjart B, Höppener DJ, et al. Salvage treatment for recurrences after first resection of colorectal liver metastases: the impact of histopathological growth patterns[J].Clin Exp Metastasis,2019,36(2): 109-118. DOI:10.1007/s10585-019-09960-7.
[26]	Wei M, Zhang Y, Yang X, et al. Claudin-2 promotes colorectal cancer growth and metastasis by suppressing NDRG1 transcription[J].Clin Transl Med,2021,11(12): e667. DOI:10.1002/ctm2.667. pmid:34965023
[27]	Paquet-Fifield S, Koh SL, Cheng L, et al. Tight junction protein claudin-2 promotes self-renewal of human colorectal cancer stem-like cells[J].Cancer Res,2018,78(11): 2925-2938. DOI:10.1158/0008-5472.CAN-17-1869. pmid:29510994
[28]	Wang YB, Shi Q, Li G, et al. MicroRNA-488 inhibits progression of colorectal cancer via inhibition of the mitogen-activated protein kinase pathway by targeting claudin-2[J].Am J Physiol Cell Physiol,2019,316(1): C33-C47. DOI:10.1152/ajpcell.00047.2018.
[29]	Tabariès S, Annis MG, Lazaris A, et al. Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern[J].Commun Biol,2021,4(1): 657. DOI:10.1038/s42003-021-02189-9. pmid:34079064
[30]	Cheng J, Wei J, Tong T, et al. Prediction of histopathologic growth patterns of colorectal liver metastases with a noninvasive imaging method[J].Ann Surg Oncol,2019,26(13): 4587-4598. DOI:10.1245/s10434-019-07910-x. pmid:31605342
[31]	Han Y, Chai F, Wei J, et al. Identification of predominant histopathological growth patterns of colorectal liver metastasis by multi-habitat and multi-sequence based radiomics analysis[J].Front Oncol,2020,10: 1363. DOI:10.3389/fonc.2020.01363. pmid:32923388
[32]	Starmans MPA, Buisman FE, Renckens M, et al. Distinguishing pure histopathological growth patterns of colorectal liver metastases on CT using deep learning and radiomics: a pilot study[J].Clin Exp Metastasis,2021,38(5): 483-494. DOI:10.1007/s10585-021-10119-6.